1
King Terry D, Mills Noel L: Shunt defect closure system. Alton Ochsner Medical Foundation, Pugh & Laiche, April 1, 1975: US3874388 (1208 worldwide citation)

A method and apparatus for closing off a septal defect or shunt in the intravascular system or the great vessels including a pair of opposed, umbrella-like elements locked together in face-to-face relationship on opposite sides of the septal defect, thereby closing it. The dual umbrella-like closure ...


2
Richard Re, Julia Cook: Inhibition of cellular proliferation by oligonucleotide binding to a chromosomal binding site for p53 protein. Alton Ochsner Medical Foundation, Scully Scott Murphy & Presser, November 11, 2003: US06645944 (4 worldwide citation)

The present invention provides methods for inhibiting cell growth by providing a growing cell with an oligonucleotide capable of binding to a chromosomal binding site for p53 protein. Moreover, in a preferred embodiment these methods can be used for preventing and treating cancer.


3
King Terry D, Mills Noel L: Systeme dobturation dintercommunications vasculaires, Shunt defect closure system. Alton Ochsner Medical Foundation, January 2, 1979: CA1045304 (3 worldwide citation)

- S P E C I F I C A T I O N - SHUNT DEFECT CLOSURE SYSTEM Abstract of the Disclosure A method and apparatus for closing off a septaldefect or shunt in the intravascular system or the greatvessels including a pair of opposed, umbrella-like elementslocked together in face-to-face relationship on oppos ...


4
Richard Re, Julia Cook: Inhibition of cellular proliferation in vitro by oligonucleotide binding to a chromosomal binding site for p53 protein. Alton Ochsner Medical Foundation, Scully Scott Murphy & Presser, October 16, 2001: US06303328 (1 worldwide citation)

The present invention provides methods for inhibiting cell growth by providing a growing cell with an oligonucleotide capable of binding to a chromosomal binding site for p53 protein. Moreover, in a preferred embodiment these methods can be used for preventing and treating cancer.


5
Richard Re, Julia Cook: Oligonucleotide which binds to a chromosomal binding site for p53 protein. Alton Ochsner Medical Foundation, Scully Scott Murphy & Presser, August 10, 1999: US05936079

The present invention provides methods for inhibiting cell growth by providing a growing cell with an oligonucleotide capable of binding to a chromosomal binding site for p53 protein. Moreover, in a preferred embodiment these methods can be used for preventing and treating cancer.


6
Mason Andrew, Xu Lizhe, Guo Linsheng: Retrovirus associated with primary sclerosing cholangitis. Alton Ochsner Medical Foundation, ABRAMS Samuel B, October 12, 2000: WO/2000/060127

The present invention relates first, to the identification of a retrovirus and the novel nucleotide sequences encoding a retroviral polymerase gene (POL gene) associated with the existence of primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), Crohn's disease and ulcerative colitis. Th ...


7
Mason Andrew L, Xu Lizhe, Neuberger James: Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders. Alton Ochsner Medical Foundation, ABRAMS Samuel B, December 7, 2000: WO/2000/073507

The present invention relates, first, to the discovery, identification, and characterization of novel nucleic acid molecules, that are associated with PBC, Sjögren's syndrome, scleroderma, SLE, autoimmune thyroiditis and various other connective tissue disorders. The novel nucleotide sequences of th ...


8

9
Andrew L Mason, Lizhe Xu, Linsheng Guo: Identification of a novel retrovirus associated with primary sclerosing cholangitis and autoimmune hepatitis. Alton Ochsner Medical Foundation, Jones Day, September 7, 2004: US06787303

The present invention relates first, to the identification of a retrovirus and the novel nucleotide sequences encoding a retroviral polymerase gene (POL nucleotides) associated with the existence of primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH) Crohn's disease and ulcerative ...


10
Andrew L Mason, Lizhe Xu, James Neuberger: Identification of a novel retrovirus associated with primary biliary cirrhosis and autoimmune disorders. Alton Ochsner Medical Foundation, Pennie & Edmonds, October 22, 2002: US06468737

The present invention relates, first, to the discovery, identification, and characterization of novel nucleic acid molecules, that are associated with PBC, Sjögren's syndrome, scleroderma, SLE, autoimmune thyroiditis and various other connective tissue disorders. The novel nucleotide sequences ...